March 25, 2020 / 6:39 AM / 12 days ago

BRIEF-Dermapharm Holding FY Adjusted EBITDA Up About 24% To EUR 178 Million

March 25 (Reuters) - Dermapharm Holding SE:

* GROUP REVENUE OF EUR 701 MILLION IN 2019, AROUND 23% HIGHER THAN IN PREVIOUS YEAR

* FY ADJUSTED EBITDA INCREASES BY APPROX. 24% COMPARED TO LAST YEAR TO EUR 178 MILLION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below